Do różnych konfiguracji stożka rogówki i zakaźnego zapalenia rogówki.
Profil dopasowany do grubościProfil wiązki dostarcza więcej energii na obrzeża rogówki.
Zaawansowane technologicznie akumulatoryZbudowane tak, aby wystarczyć na tysiące zabiegów.
Dostęp dla wózków inwalidzkichWygodnie traktuj osoby na wózku inwalidzkim?
Do nowoczesnego CXL: pasuje do lamp szczelinowych projektu Haag Streit i Zeiss.
Mocowanie na stoleFor classic CXL: table mount accessory available.
Zintegrowane protokołyWybierz jeden z wielu predefiniowanych protokołów klinicznych.
Zakres natężeniaDelivers 3, 9, 15, 18 and 30 mW/cm².
Urządzenie C-eye jest dostępne w sprzedaży z oznaczeniem CE w zakresie następujących wskazań: stożek rogówki, ektazja po LASIK/PRK, zwyrodnienie brzeżne przezroczyste (PMD), zakaźne zapalenie rogówki, nieinfekcyjne rozmiękanie rogówki, keratopatia pęcherzowa.
Urządzenie C-eye firmy EMAGine wprowadza technologię cross-linking do lampy szczelinowej. Proste, efektywne i bezpieczne: dla początkujących użytkowników i ekspertów.
Wykonuj CXL na lampie szczelinowej lub korzystaj z urządzenia C-eye tak, jak z każdego innego urządzenia CXL: zamocowanego na stole, w sali operacyjnej.
Pracujesz w różnych miejscach? Zabierz urządzenie C-eye dokądkolwiek się udajesz. Naładuj przez USB-C ładowarką do smartfona lub za pomocą laptopa.
Redukuje czas i koszty związane z wykonywaniem CXL
Remember that every cross-linking procedure not only improves biomechanics, it also ?disinfects? the cornea by directly killing all micro-organisms and by inhibiting cellular replication. This is why a cornea at the end of every CXL and PACK-CXL procedure is ?sterile?. And by the way: office-based cataract surgery i office-based intravitreal injections have been performed in many thousands of cases without increased infection risk.
Irradiation time is not too long. Current modern protocols are integrated in the C-eye device and treat in as little as 10 minutes (CXL) and 4 minutes (PACK-CXL). See the published approach tutaj.
We need 3 elements for successful cross-linking: UV light, oxygen and riboflavin. Both UV light and oxygen do not ?care? whether the patient is laying down or sitting. As for riboflavin, published research shows that riboflavin concentration is stable in the upright position for up to 60 minutes - much longer than we need for a CXL treatment.
Offer the patient the comfortable surgeon?s chair with the armrest and take the extra time to ensure that the patient is well-adjusted. Then, the patient is very comfortable.
Fixation is no issue. Offer the patient the fixation target that most slit lamps offer (for retinal examination) and the patient will keep a very steady fixation, as you can see tutaj.
Find more answers in our FAQ section.
Najbardziej wszechstronna i wszechstronna dostępna technologia CXL.
The C-eye device fits to a number of Haag-Streit and Zeiss type slit lamps. Find here the complete list of compatible slit lamps
One Riboflavin for
Keratoconus and Keratitis
EMAGine’s Medical Director, Prof. Farhad Hafezi, and its CEO, Nikki Hafezi, presented remotely at the CXL Experts’ Summer Meeting 2023,
The article by Lu et al. reports an in vitro study, conducted to determine whether high-fluence PACK-CXL can be accelerated while still maintaining its antibacterial efficacy. The study found that high-fluence PACK-CXL did indeed decrease the bacterial concentration of several clinically significant bacterial strains, including S. aureus, P. aeruginosa, and S. epidermidis. These strains are commonly implicated in bacterial keratitis and contact lens-associated keratitis. Furthermore, the authors found that higher total fluence PACK-CXL protocols led to a corresponding increase in bacterial killing ratio (BKR).
Prof. Farhad Hafezi, MD, PhD, FARVO is the Medical Director at The ELZA Institute, was recently interviewed by Ocular Surgery News
The advantages of performing corneal cross-linking (CXL) at the slit lamp are well established. It brings CXL out of the
It has been quite the debate. Should surgeons drop riboflavin onto the cornea during the UV irradiation part of a
Photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL) has progressed a great deal since it was first developed (1) as a treatment
EMAGine’s Chief Scientific Officer, Professor Farhad Hafezi of the ELZA Institute in Zurich, Switzerland, has prepared a presentation that provides a comprehensive overview of how oxygen concentration is at the center of all these decisions.
stycze? 21, 2022
NUHS 36th Anniversary Conference
Location: Singapore
Language: English
stycze? 15, 2022
Muscat International Ophthalmology Conference (MIOC)
Location: Muscat, Oman
Language: English
grudzie? 4, 2021
Kölner Adventssymposium 2021
Location: Köln, Germany
Language: German
listopad 25, 2021
Middle East Africa Council of Ophthalmology
Location: Dubai, UAE
Language: English
listopad 18, 2021
14th World Down Syndrome Congress
Location: Dubai, UAE
Language: English
listopad 11, 2021
La Société Marocaine de la chirurgie réfractive
Location: Rabat, Morocco
Language: French
listopad 4, 2021
Sorocaba Eye Bank
Location: Brazylia
Language: English
pa?dziernik 28, 2021
Emirates Society Of Ophthalmology
Location: Dubai, UAE
Language: English
pa?dziernik 23, 2021
LV Prasad Eye Institute
Location: Hyderabad, India
Language: English
pa?dziernik 23, 2021
65th Brazilian Congress of Ophthalmology
Location: Natal, Brazil
Language: English
